COGNITION THERAPEUTICS INC (CGTX:NASDAQ)
$1.17 0.05 (4.4643%)
Analysed COGNITION THERAPEUTICS INC (CGTX:NASDAQ) News Sources
Cognition Therapeutics Targets Faster DLB Psychosis Path as Zervimesine Nears Late-Stage Plans
13-04-2026
marketbeat.com
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
07-04-2026
yahoo.com
Cognition Therapeutics CEO Issues Letter to Shareholders
31-03-2026
yahoo.com
Cognition Therapeutics Inc (CGTX) Q4 2025 Earnings Call Highlights: Promising Developments in ...
26-03-2026
yahoo.com
Cognition Therapeutics Q4 Earnings Call Highlights
26-03-2026
marketbeat.com
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
26-03-2026
yahoo.com
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
23-03-2026
yahoo.com
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
17-03-2026
yahoo.com
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
02-03-2026
yahoo.com
Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
05-02-2026
yahoo.com
What is the current price of COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?
The current price of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is $1.17.
COGNITION THERAPEUTICS INC (CGTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) since the previous trading day is $0.05.
COGNITION THERAPEUTICS INC (CGTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) since the previous trading day is 4.4643%.
What is the most recent average sentiment score for COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?
The most recent average sentiment score for COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?
The most recent sentiment for COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is .
SEC-8K** Filing Available For COGNITION THERAPEUTICS INC (CGTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.